Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Cedar Grove returned 12.8% in Q2 2026, rebounding from Q1 losses by diversifying into 16 positions across healthcare, biotech, and consumer sectors while aggressively shorting overvalued names. The manager explicitly avoids the AI momentum trade, instead focusing on unloved small-cap fundamentals including telehealth leader HIMS, gene therapy plays, and grid modernization. Patience and long-term discipline anchor the strategy amid market volatility.
Full Quick Take
Cedar Grove returned 12.8% in Q2 2026, rebounding from Q1 losses by diversifying into 16 positions across healthcare, biotech, and consumer sectors while aggressively shorting overvalued names. The manager explicitly avoids the AI momentum trade, instead focusing on unloved small-cap fundamentals including telehealth leader HIMS, gene therapy plays, and grid modernization. Patience and long-term discipline anchor the strategy amid market volatility.
Springview Capital focuses on long-term outperformance through conservative, concentrated investments in high-quality, non-cyclical companies. Despite lagging the S&P 500's late-year cyclical rally in 2023, the fund achieved a solid +15.3% net return. Moving forward, the manager remains committed to its core compounding strategy, while adjusting short-side risk controls to mitigate future drag.
Full Quick Take
Springview Capital focuses on long-term outperformance through conservative, concentrated investments in high-quality, non-cyclical companies. Despite lagging the S&P 500's late-year cyclical rally in 2023, the fund achieved a solid +15.3% net return. Moving forward, the manager remains committed to its core compounding strategy, while adjusting short-side risk controls to mitigate future drag.
Long/short equity fund with 7.8% Q3 return driven by event-driven arbitrage and catalyst-driven shorts. Low net exposure strategy focuses on special situations with concrete catalysts. Portfolio concentrated in industrials and consumer sectors. Manager maintains conservative market outlook amid rising rates while appropriately sizing high-conviction opportunities with near-term catalysts.
Full Quick Take
Long/short equity fund with 7.8% Q3 return driven by event-driven arbitrage and catalyst-driven shorts. Low net exposure strategy focuses on special situations with concrete catalysts. Portfolio concentrated in industrials and consumer sectors. Manager maintains conservative market outlook amid rising rates while appropriately sizing high-conviction opportunities with near-term catalysts.
